The HAV-IgM Antibody – Serum Test is a diagnostic blood test used to detect Immunoglobulin M (IgM) antibodies produced in response to the Hepatitis A virus (HAV). The presence of IgM antibodies indicates a recent or acute infection.
Hepatitis A is a viral infection that affects the liver and is commonly transmitted through contaminated food or water. Early detection is important to manage symptoms, prevent complications, and reduce the spread of infection.
The purpose of this test is to:
The HAV IgM Antibody – Serum test detects Immunoglobulin M (IgM) antibodies against the hepatitis A virus (HAV) in the blood. These antibodies typically appear early in the course of infection and are an important marker for recent or acute hepatitis A infection.
The test is commonly recommended when a person develops symptoms suggestive of hepatitis A, such as fever, tiredness, loss of appetite, nausea, vomiting, abdominal discomfort, dark urine, pale stools, or yellowing of the skin and eyes (jaundice).
A positive HAV IgM result generally supports a diagnosis of acute or recent hepatitis A infection. The result should be interpreted along with symptoms, liver function tests, and other clinical findings.
1. What does a positive HAV IgM result mean?
A positive HAV IgM result generally indicates a recent or current hepatitis A infection. It is one of the primary laboratory markers used to diagnose acute hepatitis A.
2. How is HAV IgM different from HAV IgG?
HAV IgM generally indicates recent or acute infection, whereas HAV IgG generally indicates immunity resulting from a previous infection or vaccination.
3. What symptoms may lead a doctor to recommend an HAV IgM test?
The test may be recommended for symptoms such as jaundice, dark urine, fatigue, nausea, vomiting, loss of appetite, abdominal discomfort, and fever, particularly when acute viral hepatitis is suspected.